F
Faes Farma SA
MAD:FAE
Faes Farma SA
MAD:FAE
Price:
3.89
EUR
-4.66%
Market Cap:
1.2B
EUR
Balance Sheet
Balance Sheet Decomposition
Faes Farma SA
Faes Farma SA
| Current Assets | 333.7m |
| Cash & Short-Term Investments | 72.1m |
| Receivables | 119.1m |
| Other Current Assets | 142.5m |
| Non-Current Assets | 519.4m |
| Long-Term Investments | 1.7m |
| PP&E | 300.9m |
| Intangibles | 184.2m |
| Other Non-Current Assets | 32.5m |
Balance Sheet
Faes Farma SA
Faes Farma SA
Currency: EUR
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
26
|
59
|
43
|
76
|
53
|
91
|
70
|
66
|
35
|
64
|
|
| Cash Equivalents |
26
|
59
|
43
|
76
|
53
|
91
|
70
|
66
|
35
|
64
|
|
| Short-Term Investments |
7
|
7
|
0
|
0
|
1
|
2
|
3
|
18
|
13
|
8
|
|
| Total Receivables |
46
|
49
|
76
|
82
|
97
|
105
|
112
|
114
|
114
|
118
|
|
| Accounts Receivables |
43
|
46
|
72
|
77
|
90
|
99
|
101
|
101
|
114
|
109
|
|
| Other Receivables |
3
|
3
|
4
|
4
|
6
|
6
|
11
|
12
|
0
|
10
|
|
| Inventory |
34
|
38
|
50
|
59
|
71
|
92
|
107
|
115
|
129
|
143
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Assets |
113
|
154
|
170
|
218
|
223
|
290
|
294
|
313
|
290
|
334
|
|
| PP&E Net |
30
|
38
|
61
|
67
|
84
|
95
|
140
|
206
|
281
|
301
|
|
| PP&E Gross |
30
|
38
|
61
|
67
|
84
|
95
|
140
|
206
|
281
|
301
|
|
| Accumulated Depreciation |
58
|
59
|
60
|
63
|
67
|
72
|
77
|
82
|
87
|
92
|
|
| Intangible Assets |
76
|
73
|
111
|
112
|
107
|
113
|
129
|
127
|
185
|
128
|
|
| Goodwill |
17
|
17
|
53
|
54
|
62
|
53
|
53
|
52
|
56
|
57
|
|
| Long-Term Investments |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
7
|
2
|
2
|
|
| Other Long-Term Assets |
52
|
47
|
33
|
19
|
16
|
29
|
26
|
21
|
19
|
33
|
|
| Other Assets |
17
|
17
|
53
|
54
|
62
|
53
|
53
|
52
|
56
|
57
|
|
| Total Assets |
291
N/A
|
331
+14%
|
430
+30%
|
471
+10%
|
494
+5%
|
582
+18%
|
645
+11%
|
726
+12%
|
777
+7%
|
853
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17
|
19
|
31
|
36
|
36
|
42
|
38
|
37
|
91
|
47
|
|
| Accrued Liabilities |
6
|
7
|
8
|
11
|
12
|
13
|
12
|
12
|
13
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
7
|
11
|
12
|
13
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
5
|
48
|
7
|
7
|
7
|
17
|
8
|
5
|
|
| Other Current Liabilities |
8
|
10
|
13
|
9
|
17
|
17
|
15
|
18
|
11
|
21
|
|
| Total Current Liabilities |
31
|
38
|
56
|
104
|
72
|
85
|
79
|
94
|
87
|
103
|
|
| Long-Term Debt |
1
|
0
|
43
|
1
|
3
|
2
|
2
|
4
|
8
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
17
|
22
|
20
|
17
|
16
|
|
| Minority Interest |
0
|
0
|
1
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Other Liabilities |
4
|
8
|
10
|
6
|
5
|
5
|
5
|
5
|
1
|
5
|
|
| Total Liabilities |
36
N/A
|
46
+27%
|
110
+137%
|
111
+1%
|
81
-28%
|
110
+36%
|
109
-1%
|
125
+14%
|
114
-8%
|
127
+11%
|
|
| Equity | |||||||||||
| Common Stock |
25
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
32
|
32
|
|
| Retained Earnings |
231
|
261
|
296
|
337
|
389
|
449
|
513
|
579
|
643
|
704
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Treasury Stock |
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
11
|
11
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
3
|
0
|
|
| Total Equity |
254
N/A
|
285
+12%
|
320
+12%
|
360
+13%
|
413
+15%
|
471
+14%
|
536
+14%
|
601
+12%
|
662
+10%
|
726
+10%
|
|
| Total Liabilities & Equity |
291
N/A
|
331
+14%
|
430
+30%
|
471
+10%
|
494
+5%
|
582
+18%
|
645
+11%
|
726
+12%
|
777
+7%
|
853
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
295
|
299
|
297
|
297
|
306
|
317
|
317
|
317
|
311
|
311
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
